tiprankstipranks
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market

Foghorn Therapeutics (FHTX) Income Statement

Compare
428 Followers

Foghorn Therapeutics Income Statement

Last quarter (Q3 2024), Foghorn Therapeutics's total revenue was $7.81M, a decrease of -55.33% from the same quarter last year. In Q3, Foghorn Therapeutics's net income was $-19.12M. See Foghorn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 34.16M$ 19.23M$ 1.32M$ 430.00K$ 0.00
Gross Profit
$ -75.53M$ 19.21M$ -6.20M$ -57.28M$ -1.79M
Operating Expenses
$ 142.06M$ 136.37M$ 102.05M$ 68.96M$ 51.08M
Depreciation and Amortization
$ 3.45M$ 7.90M$ 7.51M$ 5.53M$ 1.79M
EBITDA
$ -104.45M$ -113.82M$ -96.19M$ -66.49M$ -48.80M
Operating Income
$ -107.91M$ -117.14M$ -100.73M$ -68.53M$ -51.08M
Other Income/Expenses
$ 13.71M$ 8.26M$ -586.00K$ -269.00K$ -44.00K
Pretax Income
$ -94.20M$ -108.88M$ -101.32M$ -68.80M$ -51.13M
Net Income
$ -98.43M$ -108.87M$ -103.23M$ -69.78M$ -51.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.34$ -2.62$ -2.78$ -1.90$ -1.40
Diluted EPS
$ -2.34$ -2.62$ -2.78$ -1.90$ -1.40
Weighted Average Shares Outstanding
41.97M 41.59M 37.17M 36.79M 36.82M
Weighted Average Shares Outstanding (Diluted)
41.97M 41.59M 37.17M 36.79M 36.82M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis